- Home
- COF vs BDX Comparison
COF vs BDX Comparison
Compare COF & BDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COF
- BDX
- Stock Information
- Founded
- COF 1988
- BDX 1897
- Country
- COF United States
- BDX United States
- Employees
- COF N/A
- BDX N/A
- Industry
- COF Major Banks
- BDX Medical/Dental Instruments
- Sector
- COF Finance
- BDX Health Care
- Exchange
- COF Nasdaq
- BDX Nasdaq
- Market Cap
- COF 60.4B
- BDX 68.0B
- IPO Year
- COF 1994
- BDX 1962
- Fundamental
- Price
- COF $187.08
- BDX $221.25
- Analyst Decision
- COF Buy
- BDX Strong Buy
- Analyst Count
- COF 19
- BDX 7
- Target Price
- COF $160.44
- BDX $283.00
- AVG Volume (30 Days)
- COF 3.5M
- BDX 2.0M
- Earning Date
- COF 01-23-2025
- BDX 11-07-2024
- Dividend Yield
- COF 1.28%
- BDX 1.72%
- EPS Growth
- COF N/A
- BDX 18.61
- EPS
- COF 10.59
- BDX 5.86
- Revenue
- COF $26,497,000,000.00
- BDX $20,178,000,000.00
- Revenue This Year
- COF N/A
- BDX $10.16
- Revenue Next Year
- COF $5.20
- BDX $5.05
- P/E Ratio
- COF $17.66
- BDX $37.76
- Revenue Growth
- COF 0.61
- BDX 4.16
- 52 Week Low
- COF $113.42
- BDX $218.75
- 52 Week High
- COF $198.30
- BDX $249.89
- Technical
- Relative Strength Index (RSI)
- COF 60.21
- BDX 36.07
- Support Level
- COF $179.08
- BDX $220.29
- Resistance Level
- COF $194.30
- BDX $223.84
- Average True Range (ATR)
- COF 3.63
- BDX 3.46
- MACD
- COF -0.71
- BDX -0.20
- Stochastic Oscillator
- COF 52.56
- BDX 8.20
About COF Capital One Financial Corporation
Capital One is a diversified financial services holding company headquartered in McLean, Virginia. Originally a spinoff of Signet Financial's credit card division in 1994, the company is now primarily involved in credit card lending, auto loans, and commercial lending.
About BDX Becton Dickinson and Company
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures pre-filled devices, diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Medical is nearly half of the total business, while BD Life Sciences (27% of 2023 revenue) and BD Interventional (24%) account for the remainder. International revenue accounts for 43% of the company's business.